Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. - Knight DA; Ngiow SF; Li M; Parmenter T; Mok S; Cass A; Haynes NM; Kinross K; Yagita H; Koya RC; Graeber TG; Ribas A; et al. (The Journal of clinical investigation, 2023)